DORZOLAMIDE HYDROCHLORIDE

N/A

Manufactured by Micro Labs Limited

5,992 FDA adverse event reports analyzed

Last updated: 2026-04-15

About DORZOLAMIDE HYDROCHLORIDE

DORZOLAMIDE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Micro Labs Limited. The most commonly reported adverse reactions for DORZOLAMIDE HYDROCHLORIDE include DRUG INEFFECTIVE, TREATMENT FAILURE, OFF LABEL USE, FATIGUE, EYE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DORZOLAMIDE HYDROCHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE201 reports
TREATMENT FAILURE152 reports
OFF LABEL USE143 reports
FATIGUE131 reports
EYE PAIN129 reports
EYE IRRITATION122 reports
HEADACHE114 reports
PAIN110 reports
CONDITION AGGRAVATED108 reports
WEIGHT DECREASED94 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION93 reports
RASH92 reports
PAIN IN EXTREMITY90 reports
PRODUCT DOSE OMISSION ISSUE89 reports
PRODUCT USE IN UNAPPROVED INDICATION83 reports
COVID 1981 reports
ABDOMINAL DISCOMFORT79 reports
PALPITATIONS79 reports
SOMNOLENCE77 reports
CONFUSIONAL STATE76 reports
DYSGEUSIA76 reports
CEREBROVASCULAR ACCIDENT74 reports
INTENTIONAL PRODUCT USE ISSUE74 reports
RECTAL HAEMORRHAGE74 reports
STRESS74 reports
PYREXIA73 reports
DEPRESSION72 reports
TINNITUS72 reports
DEEP VEIN THROMBOSIS71 reports
ARTHRITIS70 reports
BRONCHIECTASIS69 reports
HAEMATOCHEZIA69 reports
ACCIDENTAL OVERDOSE68 reports
COLITIS ULCERATIVE68 reports
ECZEMA68 reports
FREQUENT BOWEL MOVEMENTS68 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES68 reports
MIGRAINE68 reports
MEDICATION ERROR67 reports
VERTIGO67 reports
DYSPNOEA66 reports
GINGIVAL PAIN66 reports
IMPAIRED WORK ABILITY66 reports
PULMONARY EMBOLISM66 reports
VISION BLURRED66 reports
NIGHTMARE65 reports
STEROID DEPENDENCE65 reports
SWOLLEN TONGUE65 reports
SYSTEMIC LUPUS ERYTHEMATOSUS65 reports
BURNS SECOND DEGREE64 reports
CARDIAC MURMUR64 reports
CATARRH64 reports
HYPOPNOEA64 reports
OCULAR HYPERAEMIA64 reports
PAROSMIA64 reports
RHINITIS64 reports
TUBULOINTERSTITIAL NEPHRITIS63 reports
INTRAOCULAR PRESSURE INCREASED62 reports
ADVERSE DRUG REACTION56 reports
ALCOHOL POISONING56 reports
DIZZINESS56 reports
IMPAIRED QUALITY OF LIFE54 reports
VISUAL IMPAIRMENT47 reports
NAUSEA46 reports
GLAUCOMA43 reports
HYPERSENSITIVITY41 reports
MALAISE41 reports
COUGH40 reports
DIARRHOEA39 reports
PRODUCT CONTAINER ISSUE38 reports
PRODUCT QUALITY ISSUE38 reports
EYE PRURITUS36 reports
GAIT DISTURBANCE33 reports
DRUG HYPERSENSITIVITY30 reports
PRURITUS28 reports
ASTHENIA27 reports
DEATH27 reports
EYE SWELLING26 reports
FALL26 reports
NO ADVERSE EVENT25 reports
SCIATICA25 reports
ACUTE KIDNEY INJURY24 reports
CATARACT23 reports
DRY EYE23 reports
INJECTION SITE REACTION23 reports
PRODUCT USE ISSUE23 reports
RHEUMATOID ARTHRITIS23 reports
VOMITING23 reports
HAND DEFORMITY22 reports
DECREASED APPETITE21 reports
LACRIMATION INCREASED21 reports
OCULAR DISCOMFORT20 reports
PNEUMONIA20 reports
PRODUCT STORAGE ERROR20 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS20 reports
BLINDNESS19 reports
MUSCLE SPASMS19 reports
ARTHRALGIA18 reports
BLOOD PRESSURE INCREASED18 reports
CONSTIPATION18 reports

Report Outcomes

Out of 1,621 classified reports for DORZOLAMIDE HYDROCHLORIDE:

Serious 48.9%Non-Serious 51.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female855 (56.3%)
Male664 (43.7%)
Unknown1 (0.1%)

Reports by Age

Age 5360 reports
Age 7438 reports
Age 7033 reports
Age 8032 reports
Age 7531 reports
Age 8231 reports
Age 6928 reports
Age 7325 reports
Age 7625 reports
Age 8325 reports
Age 8124 reports
Age 8423 reports
Age 7722 reports
Age 7822 reports
Age 6719 reports
Age 7119 reports
Age 7919 reports
Age 8919 reports
Age 6118 reports
Age 8718 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with DORZOLAMIDE HYDROCHLORIDE?

This profile reflects 5,992 FDA FAERS reports that mention DORZOLAMIDE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for DORZOLAMIDE HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, TREATMENT FAILURE, OFF LABEL USE, FATIGUE, EYE PAIN, EYE IRRITATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures DORZOLAMIDE HYDROCHLORIDE?

Labeling and FAERS entries often list Micro Labs Limited in connection with DORZOLAMIDE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.